Eli Lilly & Co. (LLY)

1108.09 +44.05 (+4.14%) USD  |  NYSE  |  Jan 07, 16:00
1107.90 -0.19 (-0.02%) Pre-Market: 08:18
More

Eli Lilly Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Viking Therapeutics, Inc. --
Moderna, Inc. Upgrade